ophthalmic steroids
Showing 1 - 25 of 2,432
Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Descemet Membrane Endothelial Keratoplasty (DMEK) Trial
Recruiting
- Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
- Descemet Membrane Endothelial Keratoplasty (DMEK)
- Nepafenac Ophthalmic
- Dexamethasone Ophthalmic
-
Oslo, NorwayDepartment of Ophthalmology, Oslo University Hospital
Nov 26, 2022
Cataract Surgery Trial (Nepafenac Ophthalmic, Dexamethasone Ophthalmic)
Recruiting
- Cataract Surgery
- Nepafenac Ophthalmic
- Dexamethasone Ophthalmic
-
Oslo, NorwayDepartment of Ophthalmology, Oslo University Hospital
Nov 26, 2022
Pseudophakic Bullous Keratopathy, Fuchs' Endothelial Dystrophy, Intraocular Pressure Trial (Fluorometholone 0.1% Oph Susp,
Not yet recruiting
- Pseudophakic Bullous Keratopathy
- +2 more
- Fluorometholone 0.1% Oph Susp
- +2 more
- (no location specified)
Feb 7, 2023
Keratitis Bacterial Trial in San Francisco, Miami, Madurai (Moxifloxacin Ophthalmic, Difluprednate Ophthalmic, Riboflavin
Recruiting
- Keratitis Bacterial
- Moxifloxacin Ophthalmic
- +3 more
-
San Francisco, California
- +2 more
Dec 1, 2021
Allergic Conjunctivitis Trial in Andover (Prednisolone Acetate 1%, Prednisolone Acetate 0.12%, Loteprednol Etabonate 0.2%)
Completed
- Allergic Conjunctivitis
- Prednisolone Acetate 1%
- +3 more
-
Andover, MassachusettsOphthalmic Research Associates
Aug 19, 2020
Allergic Conjunctivitis Trial in Andover (Prednisolone Sodium Phosphate Ophthalmic Solution 1%, Tears Naturale II Ophthalmic
Completed
- Allergic Conjunctivitis
- Prednisolone Sodium Phosphate Ophthalmic Solution 1%
- Tears Naturale II Ophthalmic Solution
-
Andover, MassachusettsAndover Eye Associates
Mar 13, 2019
Dry Eye Trial in Baltimore (Sustained Release Dexamethasone, 0.4 mg, E-Caprolactone-L-Lactide copolymer (PCL) punctal plug)
Recruiting
- Dry Eye
- Sustained Release Dexamethasone, 0.4 mg
- E-Caprolactone-L-Lactide copolymer (PCL) punctal plug
-
Baltimore, MarylandWilmer Eye Institute, Johns Hopkins School of Medicine
Jan 24, 2022
Cataract Trial in Northbrook (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1%)
Enrolling by invitation
- Cataract
- Dextenza 0.4Mg Ophthalmic Insert
- Prednisolone Acetate 1%
-
Northbrook, IllinoisWyse Eyecare
Jan 17, 2023
Chronic Central Serous Chorioretinopathy Trial in Nijmegen, Rotterdam (steroid eye drops, Placebo)
Not yet recruiting
- Chronic Central Serous Chorioretinopathy
- steroid eye drops
- Placebo
-
Nijmegen, Netherlands
- +1 more
Nov 21, 2022
Keratoconus, Unstable, Collagen Crosslinking, Postoperative Pain Trial in Babylon (Dextenza, Prednisolone Acetate)
Active, not recruiting
- Keratoconus, Unstable
- +2 more
- Dextenza
- Prednisolone Acetate
-
Babylon, New YorkSightMD
Jan 18, 2022
Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Travoprost Ophthalmic Topical Cream low-dose, Travoprost
Not yet recruiting
- Open Angle Glaucoma
- Ocular Hypertension
- Travoprost Ophthalmic Topical Cream low-dose
- +4 more
-
Newport Beach, CaliforniaGlaukos Clinical Study Site
Nov 22, 2023
Optic Neuritis, Neuromyelitis Optica, Multiple Sclerosis Trial in Fort-de-France (Neuro-ophtalmology examination)
Recruiting
- Optic Neuritis
- +2 more
- Neuro-ophtalmology examination
-
Fort-de-France, FranceCHU of Martinique
Feb 22, 2022
Graft Vs Host Disease Trial in Boston (DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use, Regular
Withdrawn
- Graft Vs Host Disease
- DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use
- Regular dissolvable intracanalicular plug
-
Boston, MassachusettsMass Eye and Ear
Dec 14, 2021
Vernal Keratoconjunctivitis Trial in Assiut (Prednisolone (as Acetate), CycloSPORINE Ophthalmic Suspension, LTacrolimus Topical)
Not yet recruiting
- Vernal Keratoconjunctivitis
- Prednisolone (as Acetate)
- +2 more
-
Assiut, EgyptAssiut University Hospital
Jan 10, 2021
Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain Trial in Cleveland (Dexamethasone Ophthalmic Insert,
Enrolling by invitation
- Vitreoretinal Surgery
- +3 more
- Dexamethasone Ophthalmic Insert
- Prednisolone Acetate 1% Oph Susp
-
Cleveland, OhioCole Eye Institute, Cleveland Clinic
Feb 24, 2022
Thyroid-Associated Ophthalmopathy Trial (Sirolimus 1 mg Oral Tablet, Methylprednisolone)
Not yet recruiting
- Thyroid-Associated Ophthalmopathy
- Sirolimus 1 mg Oral Tablet
- Methylprednisolone
- (no location specified)
Mar 18, 2022
Pediatric Glaucoma Trial (Group A :combined phacoaspiration and angle surgery, Group B : phacoaspiration only)
Enrolling by invitation
- Pediatric Glaucoma
- Group A :combined phacoaspiration and angle surgery
- Group B : phacoaspiration only
-
Mansoura, Dakahlia, EgyptDina Abd Elfattah
Sep 3, 2022
Primary Open Angle Glaucoma, Ocular Hypertension Trial in Glendale, Newport Beach, Cranberry Township (SBI-100 Ophthalmic
Recruiting
- Primary Open Angle Glaucoma
- Ocular Hypertension
- SBI-100 Ophthalmic Emulsion, 0.5%
- +2 more
-
Glendale, California
- +2 more
Nov 17, 2023
Glaucoma, Open-Angle, Hypertension, Ocular Trial in Austin (NCX 470, Latanoprost 0.005%)
Completed
- Glaucoma, Open-Angle
- Hypertension, Ocular
- NCX 470
- Latanoprost 0.005%
-
Austin, TexasTexan Eye
Nov 9, 2022
Dry Eye Disease Trial in Bellaire (Topical spironolactone ophthalmic solution, 0.005 mg/cc, Placebo)
Not yet recruiting
- Dry Eye Disease
- Topical spironolactone ophthalmic solution, 0.005 mg/cc
- Placebo
-
Bellaire, TexasRichard W Yee, MD PLLC
Aug 16, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Nashville (Itacitinib, Corticosteroid, Endoscopic
Not yet recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Itacitinib
- +4 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Dec 20, 2022
Dry Eye Syndromes, Cataract Trial in Haugesund (Lubricant Eye Drops, Preservative Free, Preservative)
Recruiting
- Dry Eye Syndromes
- Cataract
- Lubricant Eye Drops
- +2 more
-
Haugesund, NorwayIfocus øyeklinikk
Jun 21, 2022
Conjunctivitis, Allergic Trial in United States (ADX-102 Ophthalmic Drops (0.5%), ADX-102 Ophthalmic Drops (0.1%), Vehicle of
Completed
- Conjunctivitis, Allergic
- ADX-102 Ophthalmic Drops (0.5%)
- +2 more
-
Morrow, Georgia
- +4 more
Dec 14, 2022
Allergic Conjunctivitis Trial in Adelaide (MDI-1228_mesylate Ophthalmic Solution, Placebo)
Recruiting
- Allergic Conjunctivitis
- MDI-1228_mesylate Ophthalmic Solution
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Jul 24, 2023
Post Procedural Infection Trial in Brecksville (Dexamethasone ophthalmic insert 0.4 mg)
Completed
- Post Procedural Infection
- Dexamethasone ophthalmic insert 0.4 mg
-
Brecksville, OhioCleveland Eye Clinic
Jul 26, 2021